These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3710427)

  • 1. Serum hyaluronate in liver diseases: study by enzymoimmunological assay.
    Frébourg T; Delpech B; Bercoff E; Senant J; Bertrand P; Deugnier Y; Bourreille J
    Hepatology; 1986; 6(3):392-5. PubMed ID: 3710427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum levels of hyaluronate in liver disease.
    Engström-Laurent A; Lööf L; Nyberg A; Schröder T
    Hepatology; 1985; 5(4):638-42. PubMed ID: 4018736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The extracellular matrix and liver disease: a study with enzymoimmunological assay].
    Gao F; Kong XT; Wang XL
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):109-12. PubMed ID: 8070290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hyaluronate correlates with histological progression in alcoholic liver disease.
    Stickel F; Poeschl G; Schuppan D; Conradt C; Strenge-Hesse A; Fuchs FS; Hofmann WJ; Seitz HK
    Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):945-50. PubMed ID: 12923365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage.
    Nyberg A; Engström-Laurent A; Lööf L
    Hepatology; 1988; 8(1):142-6. PubMed ID: 3338702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma fibronectin concentrations in patients with liver diseases.
    Gluud C; Dejgaard A; Clemmensen I
    Scand J Clin Lab Invest; 1983 Oct; 43(6):533-7. PubMed ID: 6658370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum beta2-microglobulin in liver disease.
    Hällgren R
    Scand J Clin Lab Invest; 1979 Sep; 39(5):441-7. PubMed ID: 93302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease.
    Müller C; Knoflach P; Zielinski CC
    Hepatology; 1989 Dec; 10(6):928-32. PubMed ID: 2583687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum procollagen III peptide in alcoholic and other chronic liver diseases.
    Bell H; Raknerud N; Orjasaeter H; Haug E
    Scand J Gastroenterol; 1989 Dec; 24(10):1217-22. PubMed ID: 2602904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease.
    Henriksen JH; Bentsen KD; Laurent TC
    J Hepatol; 1988 Apr; 6(2):158-66. PubMed ID: 3411097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
    Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
    Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease.
    Tran A; Hastier P; Barjoan EM; Demuth N; Pradier C; Saint-Paul MC; Guzman-Granier E; Chevallier P; Tran C; Longo F; Schneider S; Piche T; Hebuterne X; Benzaken S; Rampal P
    Gastroenterol Clin Biol; 2000; 24(6-7):626-30. PubMed ID: 10962384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet adhesiveness to glass beads in liver disease.
    Langley PG; Hughes RD; Williams R
    Acta Haematol; 1982; 67(2):124-7. PubMed ID: 6801894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is serum hyaluronan a helpful tool in the management of patients with liver diseases?
    Lindqvist U
    J Intern Med; 1997 Jul; 242(1):67-71. PubMed ID: 9260569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Sialic Acid Concentration and Content in ApoB-Containing Lipoproteins in Liver Diseases.
    Gudowska M; Gruszewska E; Cylwik B; Panasiuk A; Filisiak R; Szmitkowski M; Chrostek L
    Clin Lab; 2016; 62(6):1069-74. PubMed ID: 27468569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hyaluronate reflects hepatic sinusoidal capillarization.
    Ueno T; Inuzuka S; Torimura T; Tamaki S; Koh H; Kin M; Minetoma T; Kimura Y; Ohira H; Sata M
    Gastroenterology; 1993 Aug; 105(2):475-81. PubMed ID: 8335202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hyaluronate in malignant pleural mesothelioma.
    Frebourg T; Lerebours G; Delpech B; Benhamou D; Bertrand P; Maingonnat C; Boutin C; Nouvet G
    Cancer; 1987 Jun; 59(12):2104-7. PubMed ID: 3567871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
    Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
    Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum hyaluronate as a marker of hepatic derangement in acute liver damage.
    Bramley PN; Rathbone BJ; Forbes MA; Cooper EH; Losowsky MS
    J Hepatol; 1991 Jul; 13(1):8-13. PubMed ID: 1918880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.